U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07433556) titled 'Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers' on Feb. 02.
Brief Summary: A randomized, double-blinded, partial-open, placebo/active-controlled, single/multiple dosing, dose escalation phase 1 clinical trial to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of IY-828026 in healthy adult volunteers
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Healhty
Intervention:
DRUG: IY-828026
IY-828026
DRUG: Placebo
Placebo comparator
DRUG: IY-828026A
Active comparator
DRUG: IY-828026B
Active comparator
Recruitment Status: ...